ENZYME-LINKED-IMMUNOSORBENT-ASSAY AND ENZYME-LINKED COAGULATION ASSAYFOR DETECTION OF CLOSTRIDIUM-BOTULINUM NEUROTOXIN-A, NEUROTOXIN-B, AND NEUROTOXIN-E AND SOLUTION-PHASE COMPLEXES WITH DUAL-LABEL ANTIBODIES
Gj. Doellgast et al., ENZYME-LINKED-IMMUNOSORBENT-ASSAY AND ENZYME-LINKED COAGULATION ASSAYFOR DETECTION OF CLOSTRIDIUM-BOTULINUM NEUROTOXIN-A, NEUROTOXIN-B, AND NEUROTOXIN-E AND SOLUTION-PHASE COMPLEXES WITH DUAL-LABEL ANTIBODIES, Journal of clinical microbiology, 32(1), 1994, pp. 105-111
The measurement of toxins A, B, and E from Clostridium botulinum was a
ccomplished by use of a modified sandwich enzyme-linked immunosorbent
assay (ELISA) employing labeled horse antibody and either chicken anti
body or biotinylated horse antibody. The complexes formed in solution
phase were captured onto solid phases coated with rabbit anti-chicken
immunoglobulin G (chicken antibody) or avidin (biotinylated antibody).
The assay was brought to the sensitivity of the mouse bioassay (5 to
10 pg/ml, or 0.03 to 0.07 pM) by employing as labeling enzyme the fact
or X activator of Russell's viper venom (RVV-XA) and a sensitive coagu
lation-based assay amplification system known as enzyme-linked coagula
tion assay. Complex formation was found to be a slower reaction than b
inding to the capture plate, and so the assay used a preincubation ste
p to produce the solution-phase complexes before they were bound to th
e solid phase. Keeping the concentrations of Russell's viper venom fac
tor X activator antibody and capture antibody constant for diluted sam
ples and diluting complexes into buffer without keeping labeled antibo
dy concentrations constant were equivalent in allowing the detection o
f low neurotoxin concentrations. This ELISA-enzyme-linked coagulation
assay procedure is a convenient alternative to the mouse bioassay, whi
ch shows complete resolution of the neurotoxins in addition to the req
uisite sensitivity.